ABIONYX Pharma Statistics

Total Valuation

ABIONYX Pharma has a market cap or net worth of EUR 44.04 million. The enterprise value is 41.91 million.

Market Cap	44.04M
Enterprise Value	41.91M

Important Dates

The last earnings date was Thursday, March 6, 2025.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ABIONYX Pharma has 34.68 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	34.68M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	32.21%
Owned by Institutions (%)	0.03%
Float	17.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.52
EV / Sales	9.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-44.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	75,410
Profits Per Employee	-72,131
Employee Count	61
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.00% in the last 52 weeks. The beta is 0.48, so ABIONYX Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+30.00%
50-Day Moving Average	1.26
200-Day Moving Average	1.26
Relative Strength Index (RSI)	47.87
Average Volume (20 Days)	37,298

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ABIONYX Pharma had revenue of EUR 4.60 million and -4.40 million in losses.

Revenue	4.60M
Gross Profit	900,000
Operating Income	-4.40M
Pretax Income	-4.40M
Net Income	-4.40M
EBITDA	n/a
EBIT	-4.40M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.60M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 19.57%, with operating and profit margins of -95.65% and -95.65%.

Gross Margin	19.57%
Operating Margin	-95.65%
Pretax Margin	-95.65%
Profit Margin	-95.65%
EBITDA Margin	n/a
EBIT Margin	-95.65%
FCF Margin	n/a

Dividends & Yields

ABIONYX Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.99%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a